Vorexa

Vorexa
Independent research and analysis on the technologies, markets and policies shaping how organisations work.
About
What does Vorexa do?
Vorexa is an independent research and publishing organization that produces original research, data-led insights, and long-form reporting. They cover technologies, markets, and policies that redefine how organizations work, serving businesses that need evidence before opinion for their decisions. Vorexa's core offering is their published research and insights, delivered through their website and a weekly newsletter.
Where is Vorexa headquartered?
Vorexa is headquartered in United Kingdom.
When was Vorexa founded?
Vorexa was founded in 2026.
What industry does Vorexa operate in?
Vorexa operates in Market Research, Technology Analysis, Policy Analysis, Business Strategy, Industry Research.
Discover product posts across social media. ProductGPT uses AI to detect viral potential, buying intent, and conversion signals for ecommerce sellers.
Brazilian company providing business research and consulting, specializing in the real estate market.
US-based field research and survey operations across African countries with local teams and rigorous QA.
Dawnbreaker provides services to small, advanced technology firms and Federal Agencies, focusing on technology commercialization and market research.
Test ideas, messaging, and products across 10,000 distinct AI personas in seconds.
A tiny overnight crew that turns sleep into progress, delivering decision-ready reports.
Firsthand competitive intelligence for mid-market B2B SaaS. Retainer from $3,500/month.
Thornberry provides AI research agents that run on your own machine, enabling market analysis and automated trading within user-defined limits.
An entrant is a company tagged Market Research whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.
